Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients
The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Abstract
Cortical and subcortical gray matter hypointensities on T2-weighted MR images (T2WI) occur commonly in MS brains and have been related to disease duration, clinical course, and the level of neurologic disability. These hypointensities have been reported to occur in the thalamus, basal ganglia, and rolandic cortex. We assessed whether T2 hypointensity is associated with the severity of white matter plaques and atrophy of MS brains. In 114 MS patients, hypointensity of the thalamus, putamen, caudate, and sensorimotor cortex was ordinally rated against age- and gender-matched normal controls on 1.5-T MRI fast spin-echo axial T2WI. Regional and global T2 hyperintense and T1 hypointense parenchymal lesion loads were ordinally rated. Enlargement of subarachnoid and ventricular spaces (atrophy) was ordinally rated vs. age- and gender-matched normal controls. T2 hypointensity was highly, positively correlated with many other MRI variables. Regression modeling showed that T2 hypointensity was related to total atrophy, total T2 lesion load, third ventricular enlargement, parietal atrophy, and to a lesser extent, frontal T1 lesions and cerebellar T2 lesions, but not related to gadolinium enhancement. Ordinal ratings of T2 lesions and central atrophy showed high correlations with quantitative computerized assessments. We conclude that gray matter hypointensity on T2WI may reflect pathologic iron deposition and brain degeneration in MS. This T2 hypointensity is associated with brain atrophy and other MR markers of tissue damage. Further study is warranted to determine if T2 hypointensity is predictive of disease course in MS and is a useful surrogate outcome measure in therapeutic trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“iron dysregulation and/or deposition have indeed been implicated directly”
Citations
Cites
Estimating the Dimension of a Model
Schwarz, G. (1978) · The Annals of Statistics · doi:10.1214/aos/1176344136 · Cited by 47,033
Classification and Regression Trees.
Gordon, A. D., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984) · Biometrics · doi:10.2307/2530946 · Cited by 23,522
Classification and Regression Trees.
Ryzin, J. V., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1986) · Journal of the American Statistical Association · doi:10.2307/2288003 · Cited by 20,825
Classification and regression trees
Praagman, J. (1985) · European Journal of Operational Research · doi:10.1016/0377-2217(85)90321-2 · Cited by 10,053
Multivariate Adaptive Regression Splines
Friedman, J. H. (1991) · The Annals of Statistics · doi:10.1214/aos/1176347963 · Cited by 8,000
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Defining the clinical course of multiple sclerosis: Results of an international survey
Lublin, F. D., Reingold, S. C., & National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis* (1996) · Neurology · doi:10.1212/wnl.46.4.907 · Cited by 3,686
Cortical lesions in multiple sclerosis
Kidd, D., Barkhof, F., McConnell, R., Algra, P. R., Allen, I. V., & Revesz, T. (1999) · Brain · doi:10.1093/brain/122.1.17 · Cited by 766
Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS
Rudick, R. A., Fisher, E., Lee, J.-C., Simon, J., Jacobs, L., & the Multiple Sclerosis Collaborative Research Group (1999) · Neurology · doi:10.1212/wnl.53.8.1698 · Cited by 736
Self-citation
Research works printed but not linked: 5
- Bakshi, 1999, Magnetic resonance imaging T2 shortening in multiple sclerosis brains (Black T2 Lesions): a new surrogate marker of disease (abstract), Ann. Neurol., 46, 469
- Bakshi, 1999, MRI hemispheric atrophy is associated with FDG-PET hypometabolism and MRI white matter lesions in multiple sclerosis (abstract), Neurology, 52, A361
- Bakshi, R., Ariyaratana, S., Benedict, R.H.B., Jacobs, L. Fluid-attenuated inversion-recovery MRI detects cortical and juxtacortical multiple sclerosis lesions. Arch. Neurol. (in press).
- Bakshi, 2000, T2 hypointensity in gray matter of MS patients: a quantitative study (abstract), Multiple Sclerosis, 6, 413
- Bermel, 2000, Bicaudate ratio as a marker of brain atrophy in multiple sclerosis: a quantitative MRI study (abstract), J. Neuroimaging, 11, 82
Cited by
The clinico-radiological paradox in multiple sclerosis revisited
Barkhof, F. (2002) · Current Opinion in Neurology · doi:10.1097/00019052-200206000-00003 · Cited by 726
Evidence of early cortical atrophy in MS: Relevance to white matter changes and disability
De Stefano, N., Matthews, P. M., Filippi, M., Agosta, F., De Luca, M., Bartolozzi, M. L., Guidi, L., Ghezzi, A., Montanari, E., Cifelli, A., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000055926.69643.03 · Cited by 489
The measurement and clinical relevance of brain atrophy in multiple sclerosis
Bermel, R. A., & Bakshi, R. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70349-0 · Cited by 456
Self-citationKell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“…hydroxyl radicals, and it is thus of much interest that iron dysregulation and/or deposition have indeed been implicated directly (Adams 1988; Bakshi et al. 2000, 2001, 2002, 2008; Bermel et al. 2005; Brass et al. 2006a, b; Ceccarelli et al. 2009, 2010; Chard and Miller 2009; Craelius et al.…”
BackgroundBrain iron uptake and homeostatic mechanisms: An overview
Burdo, J. R., & Connor, J. R. (2003) · Biometals · doi:10.1023/a:1020718718550 · Cited by 290
“A report exists that in Multiple Sclerosis, the prototype of demyelinating diseases, iron accumulates in the basal ganglia (Bakshi et al. 2001).”
Background
Metadata
- Authors
- Bakshi, R., Dmochowski, J., Shaikh, Z. A., & Jacobs, L.
- Affiliations
- Kaleida Health (US)
- University at Buffalo, State University of New York (US)
- Corresponding author
- Bakshi, Rohit
- Venue
- Journal of the Neurological Sciences
- Publisher
- Elsevier BV
- Published
- 2001-03
- Volume
- 185
- Issue
- 1
- Pages
- 19-26
- ISSN
- 0022-510X (ISSN-L)
- OpenAlex
- W2001424726
- Cited by
- 107
- References
- 52
- Citations by year
- 2024: 1 · 2023: 1 · 2020: 1 · 2018: 2 · 2017: 4 · 2016: 3 · 2015: 1 · 2014: 6 · 2013: 5 · 2012: 7
- FWCI
- 5.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of the Neurological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- University at Buffalo
- National Institute of Neurological Disorders and Stroke (1 K23 NS 42379-01, K23NS042379)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- multiple sclerosis, brain atrophy, iron accumulation, thalamus, basal ganglia, sensorimotor cortex, T2 lesion load, MRI outcome measures, disease progression
- MeSH terms
- Adolescent, Adult, Atrophy, Brain, Female, Follow-Up Studies, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Multiple Sclerosis, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. https://app.cochat.ai/papers/10.1016/s0022-510x(01)00477-4
- The paper
- Bakshi, R., Dmochowski, J., Shaikh, Z. A., & Jacobs, L. (2001). Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. Journal of the Neurological Sciences. https://doi.org/10.1016/s0022-510x(01)00477-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.